Literature DB >> 27318373

Effect of Intra- and Extrauterine Growth on Long-Term Neurologic Outcomes of Very Preterm Infants.

Isabelle Guellec1, Alexandre Lapillonne2, Stephane Marret3, Jean-Charles Picaud4, Delphine Mitanchez5, Marie-Laure Charkaluk6, Jeanne Fresson7, Catherine Arnaud8, Cyril Flamant9, Gilles Cambonie10, Monique Kaminski6, Jean-Christophe Roze9, Pierre-Yves Ancel6.   

Abstract

OBJECTIVE: To determine whether extrauterine growth is associated with neurologic outcomes and if this association varies by prenatal growth profile. STUDY
DESIGN: For 1493 preterms from the EPIPAGE (Étude Épidémiologique sur les Petits Âges Gestationnels [Epidemiological Study on Small Gestational Ages]) cohort, appropriate for gestational-age (AGA) was defined by birth weight >-2 SD and small for gestational-age (SGA) by birth weight ≤-2 SD. Extra-uterine growth was defined by weight gain or loss between birth and 6 months by z-score change. Growth following-the-curve (FTC) was defined as weight change -1 to +1 SD, catch-down-growth (CD) as weight loss ≥1 SD, and catch-up-growth (CU) as weight gain ≥1 SD. At 5 years, a complete medical examination (n = 1305) and cognitive evaluation with the Kauffman Assessment Battery for Children (n = 1130) were performed. Behavioral difficulties at 5 years and school performance at 8 years were assessed (n = 1095).
RESULTS: Overall, 42.5% of preterms were AGA-FTC, 20.2% AGA-CD, 17.1% AGA-CU, 5.6% SGA-FTC, and 14.5% SGA-CU. Outcomes did not differ between CU and FTC preterm AGA infants. Risk of cerebral palsy was greater for AGA-CD compared with AGA-FTC (aOR 2.26 [95% CI 1.37-3.72]). As compared with children with SGA-CU, SGA-FTC children showed no significant increased risk of cognitive deficiency (aOR 1.41[0.94-2.12]) or school difficulties (aOR 1.60 [0.84-3.03]). Compared with AGA-FTC, SGA showed increased risk of cognitive deficiency (SGA-FTC aOR 2.19 [1.25-3.84]) and inattention-hyperactivity (SGA-CU aOR 1.65 [1.05-2.60]).
CONCLUSION: Deficient postnatal growth was associated with poor neurologic outcome for AGA and SGA preterm infants. CU growth does not add additional benefits. Regardless of type of postnatal growth, SGA infants showed behavioral problems and cognitive deficiency.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  extrauterine growth restriction; neurological outcome; preterm; small-for-gestational age

Mesh:

Year:  2016        PMID: 27318373     DOI: 10.1016/j.jpeds.2016.05.027

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  33 in total

1.  Association of maternal depression with dietary intake, growth, and development of preterm infants: a cohort study in Beijing, China.

Authors:  Han Wang; Hong Zhou; Yan Zhang; Yan Wang; Jing Sun
Journal:  Front Med       Date:  2017-11-27       Impact factor: 4.592

Review 2.  "Extrauterine growth restriction" and "postnatal growth failure" are misnomers for preterm infants.

Authors:  Tanis R Fenton; Barbara Cormack; Dena Goldberg; Roseann Nasser; Belal Alshaikh; Misha Eliasziw; William W Hay; Angela Hoyos; Diane Anderson; Frank Bloomfield; Ian Griffin; Nicholas Embleton; Niels Rochow; Sarah Taylor; Thibault Senterre; Richard J Schanler; Seham Elmrayed; Sharon Groh-Wargo; David Adamkin; Prakesh S Shah
Journal:  J Perinatol       Date:  2020-03-25       Impact factor: 2.521

3.  What We Do and Do Not Know about Women and Kidney Diseases; Questions Unanswered and Answers Unquestioned: Reflection on World Kidney Day and International Women's Day.

Authors:  Giorgina B Piccoli; Mona Alrukhaimi; Zhi-Hong Liu; Elena Zakharova; Adeera Levin
Journal:  Kidney Dis (Basel)       Date:  2018-02-01

4.  Association of Intrauterine Growth Restriction and Small for Gestational Age Status With Childhood Cognitive Outcomes: A Systematic Review and Meta-analysis.

Authors:  Chiara Sacchi; Claudia Marino; Chiara Nosarti; Alessio Vieno; Silvia Visentin; Alessandra Simonelli
Journal:  JAMA Pediatr       Date:  2020-08-01       Impact factor: 16.193

5.  What we do and do not know about women and kidney diseases; questions unanswered and answers unquestioned: reflection on World Kidney Day and International Women's Day.

Authors:  Giorgina Barbara Piccoli; Mona Alrukhaimi; Zhi-Hong Liu; Elena Zakharova; Adeera Levin
Journal:  J Nephrol       Date:  2018-02-20       Impact factor: 3.902

6.  What we do and do not know about women and kidney diseases: Questions unanswered and answers unquestioned : Reflection on World Kidney Day and International Woman's Day.

Authors:  Giorgina B Piccoli; Mona Alrukhaimi; Zhi-Hong Liu; Elena Zakharova; Adeera Levin
Journal:  Pediatr Nephrol       Date:  2018-03-01       Impact factor: 3.714

7.  Neurodevelopment at Age 10 Years of Children Born <28 Weeks With Fetal Growth Restriction.

Authors:  Steven J Korzeniewski; Elizabeth N Allred; Robert M Joseph; Tim Heeren; Karl C K Kuban; T Michael O'Shea; Alan Leviton
Journal:  Pediatrics       Date:  2017-10-13       Impact factor: 7.124

8.  The risk of small for gestational age in very low birth weight infants born to Asian or Pacific Islander mothers in California.

Authors:  Soon Min Lee; Lillian Sie; Jessica Liu; Jochen Profit; Henry C Lee
Journal:  J Perinatol       Date:  2020-02-12       Impact factor: 2.521

9.  Sudden vs Pressure Wean From Nasal Continuous Positive Airway Pressure in Infants Born Before 32 Weeks of Gestation: A Randomized Clinical Trial.

Authors:  Christina Friis Jensen; Anna Sellmer; Finn Ebbesen; Rasa Cipliene; Anders Johansen; Rikke Monrad Hansen; Jens Peter Nielsen; Olga Hogreffe Nikitina; Jesper Padkær Petersen; Tine Brink Henriksen
Journal:  JAMA Pediatr       Date:  2018-09-01       Impact factor: 16.193

10.  Early Lipid Intake Improves Cerebellar Growth in Very Low-Birth-Weight Preterm Infants.

Authors:  Katherine M Ottolini; Nickie Andescavage; Kushal Kapse; Marni Jacobs; Jonathan Murnick; Rebecca VanderVeer; Sudeepta Basu; Mariam Said; Catherine Limperopoulos
Journal:  JPEN J Parenter Enteral Nutr       Date:  2020-06-04       Impact factor: 4.016

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.